Clinical trial
Retrospective Study Assessing Molecular Features Predicting Response to…
NCT00491140 · Istituto Clinico Humanitas, Other · Completed
Key facts
| NCT number | NCT00491140 |
|---|---|
| Title | Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab |
| Official title | Retrospective Study Assessing Molecular Features Predicting Response or Resistance to Cetuximab Therapy in Metastatic Colorectal Cancer Patients |
| Lead sponsor | Istituto Clinico Humanitas, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Neoplasms |
| Intervention type | Genetic |
| Interventions | Gene mutations analysis and FISH |
| Enrollment | 85 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Jun 25, 2007 |
| Last update posted | Oct 1, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: